LG Life Sciences

LG Life Sciences(LGLS) spun off from LG Chem Investment as a full-fledged LG Group Affiliate in August 2002. LGLS began research in genetic engineering since 1981 and has developed and commercialized: - interferon : Intermax-gamma(1989), Intermax-alpha(1992) - hepatitis B vaccine : Euvax B(1992) - human growth hormone : Eutropin(1993) - quinolone antibiotic : Factive(2003) - degenerative arthritis treatment : Hyruan Plus(2005) - rhFSH (recombinant human follicle stimulating hormone) : Follitrope(2006) - SR-hGH (Sustained Release-human Growth Hormone) : Declage(2007)

LG Life Sciences

LG Life Sciences(LGLS) spun off from LG Chem Investment as a full-fledged LG Group Affiliate in August 2002. LGLS began research in genetic engineering since 1981 and has developed and commercialized: - interferon : Intermax-gamma(1989), Intermax-alpha(1992) - hepatitis B vaccine : Euvax B(1992) - human growth hormone : Eutropin(1993) - quinolone antibiotic : Factive(2003) - degenerative arthritis treatment : Hyruan Plus(2005) - rhFSH (recombinant human follicle stimulating hormone) : Follitrope(2006) - SR-hGH (Sustained Release-human Growth Hormone) : Declage(2007)